SUD AGM 2018, page-6

First 6 Last

Share
Profile

Follow
kippax

4,728 Posts.

239

24/06/18

17:13

Post #: 33913023
Share

Originally posted by Doole ↑

I think we may learn a bit about SC support by watching this thread. Usually CBD and others get up and support SC to the point of real fire and brimstone. Will they do that this time?

I do agree with CBD that results and effort are not the same thing and you can have one without the other, but, I disagree with CBD's assumption (and I'm guessing that he assumes) that hard work is justification for non-performance. It's not. I now many execs who keep their orgs excessively busy, but there is no focus and a gappy business plan. Those orgs continue to underperform or fail until the exec changes. It is a very painful change. I watched an org who has enormous potential (technology) do great with the R&D but fail to perform on market presence. The CEO put in enormous personal capital. He stepped aside to let the right expertise come in. The org still hasn't performed, but there is now no obstacle to performance. The new CEO is all about sales and marketing and the prev CEO stepped into a fully technical role. Now we have balance. I look forward with great confidence. Something that is missing here.

It is my personal opinion that planning has appeared to have been reactionary and very short term. I am yet to see evidence of a long-term plan that builds value until very recently. We are paying for that apparent lack of foresight. I do like the new business plan and the platform. But almost immediately we see them getting distracted with SC's fav... cancer treatment. Coincidence? That is where the last org where he was involved tripped majorly.

Here, and with the new platform, it may be a 'thing' in the way-way-way-off future but ffs we haven't even secured proof the platform works and while we chase a new shiny toy, we are still not delivering on the basics. Where are the reports about bunnies and clinical trials and, and, and... we don't appear to even be able to close our own loops, let alone business deals. And yes, I'm not surprised people report that SC is very defensive atm, BP happened on his watch and we haven't been able to sell Artie on his watch because we failed to realise you won't sell for any kind of useful price an unregistered (and therefore unrecognised by WHO) product. It's like trying to sell a block for the same price it would go with the high rise already built and furnished. Dreamin'

Sure, defensive is probably an understatement. I hope he can process stress constructively, because that person now controls the two most important jobs in our company. This continues to alarm me. Research shows that some people at this juncture work to cta and this may not be in the best interest of sh.

We wait... but I suspect we won't have too much longer (thankfully?)

Expand

Hi Doole

SC Joined SUD in July 2010 when Patterson was CEO. The Berlin Pharma announcement announcing their demise was in June 2010....before SC joined and the problems went back further with the dodgy "in kind" deal and share issues.

Since then it would be fair to say that SUDA in hindsight may have been unlucky with their choice of German legal representation and advise received.

kippax

SUD Price at posting: 0.9¢ Sentiment: Buy Disclosure: Held
5 Upvote

1 Great analysis

Reply

Top Stories

HAS

Hastings progressing Yangibana to production with lower costs

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The iron ore comeback: Can it last?

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 14 more messages in this thread...

First 6 Last

Add ALA (ASX) to my watchlist

(20min delay)
Last 15.5¢		Change -0.005(3.13%)		Mkt cap ! $163.0M

Open	High	Low	Value	Volume
16.0¢	16.0¢	15.5¢	$137.3K	869.0K

Buyers (Bids)

No.	Vol.	Price($)
8	194153	15.5¢

Sellers (Offers)

Price($)	Vol.	No.
16.0¢	271243	5

View Market Depth

No.	Vol.	Price($)
8	194153	0.155
13	519016	0.150
7	233654	0.145
5	169046	0.140
7	657000	0.135

Price($)	Vol.	No.
0.160	271243	5
0.165	755452	9
0.170	679999	9
0.175	864999	8
0.180	1194230	8

Last trade - 16.10pm 30/09/2024 (20 minute delay)

ALA (ASX) Chart

SUD AGM 2018, page-6

Hastings progressing Yangibana to production with lower costs

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The iron ore comeback: Can it last?

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

SUD AGM 2018, page-6

Top Stories

Hastings progressing Yangibana to production with lower costs

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The iron ore comeback: Can it last?

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News